Behavioral and Adaptive Status in an Experimental Model of Alzheimer's Disease in Rats

References

• Altman H. J., Crosland R. D., Jenden D. J., Berman R. F. Further characterizations of the nature of the behavioral and neurochemical effects of lesions to the nucleus basalis of Meynert in the rat. Neurobiology of Aging 1985; 6: 125–130
   PubMed Web of Science ®Google Scholar
• Anisman H., Remington G., Sklar L. S. Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance. Psychopharmacology 1979; 61: 107–124
   PubMed Web of Science ®Google Scholar
• Anisman H., Glazier S. J., Sklar L. S. Cholinergic influences on escape deficits produced by uncontrollable stress. Psychopharmacology 1981; 74: 81–87
   PubMed Web of Science ®Google Scholar
• Arai H., Kosaka K., Lizuka R. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. Journal of Neurochemistry 1984; 43: 388–393
   PubMed Web of Science ®Google Scholar
• Archer J. Tests for emotionality in rats and mice: a review. Animal Behavior 1973; 21: 205–235
   PubMed Web of Science ®Google Scholar
• Arendash G. W., Millard W. J., Dunn A. J., Meyer E. M. Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science 1987; 238: 952–956
   PubMed Web of Science ®Google Scholar
• Backhine S., Lacomblez L., Palisson E., Laurent M., Derouesne C. Relationship between primitive reflexes, extrapyramidal signs, reflective apraxia and severity of cognitive impairment in dementia of the Alzheimer type. Acta Neurologica Scandinavian 1989; 79: 38–46
   PubMed Web of Science ®Google Scholar
• Baggio G., Ferrari F. Role of brain dopaminergic mechanisms in rodent aggressive behavior: Influence of (±) N-n-propyl-norapomorphine on three experimental models. Psychopharmacology 1980; 70: 63–68
   PubMed Web of Science ®Google Scholar
• Baird J., Lang W. J. Temperature responses in the rat and cat to cholinomimetic drugs injected into the cerebral ventricles. European Journal of Pharmacology 1973; 21: 203–211
   PubMed Web of Science ®Google Scholar
• Bartus R. T., Dean R. L., Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408–417
   PubMed Web of Science ®Google Scholar
• Bell R., Hepper P. G. Catecholamines and aggression in animals. Behavioral Brain Research 1987; 23: 1–21
   PubMed Web of Science ®Google Scholar
• Bisso G. M., Diana G., Fortuna S., Meneguz A., Michalek H. Change in the distribution of acetylcholinesterase molecular forms in frontoparietal cortex of the rat following nucleus basalis lesions with kainic acid. Brain Research 1988; 449: 391–394
   PubMed Web of Science ®Google Scholar
• Coyle J. T., Price D. L., DeLong R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983; 219: 1184–1190
   PubMed Web of Science ®Google Scholar
• Davidson M., Bastiaens L., Davis B. M., Shah M. B., Davis K. L. Endocrine changes in Alzheimer's disease. Neurologic Clinics 1988; 6: 147–157
   Web of Science ®Google Scholar
• Dilsaver S. C. Cholinergic mechanisms in depression. Brain Research Reviews 1986; 11: 285–316
   Google Scholar
• Dubois B., Mayo W., Agid Y., Le Moal M., Simon H. Profound disturbances of spontaneous and learned behaviors following lesions of the nucleus basalis magnocellularis in the rat. Brain Research 1985; 338: 249–258
   PubMed Web of Science ®Google Scholar
• Engellenner W. J., Barright R. G., Dorovick P. J. Lead, age and aggression in male mice. Physiology & Behavior 1986; 36: 823–828
   PubMed Web of Science ®Google Scholar
• Fibiger H. C. The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Research Reviews 1982; 4: 327–388
   Google Scholar
• Fisher A., Brandeis R., Karton I., Pittel Z., Gurwitz D., Haring R., Sapir M, Levy A., Heldman E. (±)-cis-2-methyl-spiro(1, 3-oxathiolane-5–3′)quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. Journal of Pharmacology and Experimental Therapeutics 1991; 257: 392–403
   PubMed Web of Science ®Google Scholar
• Fitz A. G., Teri L. Depression, cognition, and functional ability in patients with Alzheimer's disease. Journal of American Geriatric Society 1994; 42: 186–191
   PubMed Web of Science ®Google Scholar
• Flicker C., Dean R. L., Watkins D. L., Fisher S. K., Bartus R. T. Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacology Biochemistry and Behavior 1983; 18: 973–981
   PubMed Web of Science ®Google Scholar
• Forstl H., Levy R., Burns A., Luthert P., Cairns N. Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease–a hypothesis. Pharmacopsychiatry 1994; 27: 11–15
   PubMed Web of Science ®Google Scholar
• Gedye A. Serotoninergic treatment for aggression in a Down's syndrome adult showing signs of Alzheimer's disease. Journal of Mental Deficiency Research 1991; 35: 247–258
   PubMedGoogle Scholar
• Gordon C. J. Thermal biology of the laboratory rat. Physiology & Behavior 1990; 47: 963–991
   PubMed Web of Science ®Google Scholar
• Gottfries C. G., Roos B. E., Winblad B. Monoamine and monoamine metabolites in the human brain post mortem in senile dementia. Acta Gerontologica 1976; 6: 429–435
   Google Scholar
• Gower A. J., Lamberty Y. The aged mouse as a model of cognitive decline with special emphasis on studies in NMR1 mice. Behavioral Brain Research 1993; 57: 163–173
   PubMed Web of Science ®Google Scholar
• Gower A. J., Rousseau D., Jasmin P., Gobert J., Hanin I., Wulfert E. Behavioral and histological effects of low concentrations of intraventricular AF64A. European Journal of Pharmacology 1989; 166: 271–281
   PubMed Web of Science ®Google Scholar
• Hartgraves S. L., Mensah P. L., Kelly P. H. Regional decrease of cortical choline acetyltransferase after lesions of the septal area and in (he area of nucleus basalis magnocellularis. Neuroscience 1982; 7: 2369–2376
   PubMed Web of Science ®Google Scholar
• Hasegawa K. Aspects of community health care of the elderly in Japan. International Journal of Mental Health 1979; 8: 36–39
   Web of Science ®Google Scholar
• Hepler D. J., Wenk G. L., Cribbs B. L., Olton D. S., Coyle J. T. Memory impairments following basal forebrain lesions. Brain Research 1985; 346: 8–14
   PubMed Web of Science ®Google Scholar
• Ishii T. Distribution of Alzheimer's neurofibrillary changes in the brainstem and hypothalamus of senile dementia. Acta Neuropathologica 1966; 6: 181–187
   PubMed Web of Science ®Google Scholar
• Janowsky D. S., El-Yousef M. K., Davis J. M., Sekerke H. J. A cholinergic-adrenergic hypothesis of mania and depressions. Lancet 1972; i: 632–635
   Google Scholar
• Kessler J., Markowitsch H. J., Sigg G. Memory related role of the posterior cholinergic system. International Journal of Neuroscience 1986; 30: 101–119
   PubMed Web of Science ®Google Scholar
• Lee D. O. F., Markesbery W. R. The hypothalamus in senile dementia of the Alzheimer type. Journal of Neuropathology and Experimental Neurology 1986; 45: 341
   Web of Science ®Google Scholar
• Leong S. S., Brown W. A. Acetylcholine and affective disorder. Journal of Neural Transmission 1987; 70: 295–312
   PubMed Web of Science ®Google Scholar
• Lerer B., Warner J., Friedman E., Vincent G., Gamzu E. Cortical cholinergic impairment and behavioral deficits produced by kainic acid lesions of rat magnocellular basal forebrain. Behavioral Neuroscience 1985; 99: 661–677
   PubMed Web of Science ®Google Scholar
• Leshner A. I., Remler H., Biegon A., Samuel D. Desmethylimipramine (DMI) counteracts learned helplessness in rats. Psychopharmacology 1979; 66: 207–208
   PubMed Web of Science ®Google Scholar
• Liu W.-F., Hu N.-W., Chien T.-F., Beaton J. M. Effects of 3-quinuclidinyl benzilate on fixed-ratio responding and open field behavior in the rat. Psychopharmacology 1983; 80: 10–13
   PubMed Web of Science ®Google Scholar
• LoConte G., Bartolini L., Casamenti F., Marconcini-Pepeu I., Pepeu G. Lesions of cholinergic fore-brain nuclei: changes in avoidance behavior and scopolamin actions. Pharmacology Biochemistry and Behavior 1982; 17: 933–937
   PubMed Web of Science ®Google Scholar
• Lomax P. Drugs and body temperature. International Review of Neurobiology 1970; 12: 1–43
   PubMedGoogle Scholar
• Maier S. F., Seligman M. F. P. Learned helplessness: theory and evidence. Journal of Experimental Psychology General 1976; 105: 3–46
   Web of Science ®Google Scholar
• Mancinelli A., Borsini F., ĎAranno V., Lecci A., Meli A. Cholinergic drug effects on antide-pressant-induced behaviour in the forced swimming test. European Journal of Pharmacology 1988; 158: 199–205
   PubMedGoogle Scholar
• Martignoni E., Petraglia F., Costa A., Bono G., Genazzani A. R., Nappi G. Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma Cortisol levels. Acta Neurologica Scandinavica 1990; 81: 452–456
   PubMed Web of Science ®Google Scholar
• Miyamoto M., Shintani M., Nagaoka A., Nagawa Y. Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks. Brain Research 1985; 328: 97–104
   PubMed Web of Science ®Google Scholar
• Nath C., Gulati A., Dhawan K. N., Gupta G. P., Bhargava K. P. Evidence for central histaminergic mechanism in foot shock aggression. Psychopharmacology 1982; 76: 228–231
   PubMed Web of Science ®Google Scholar
• Ogishima M., Hiraga Y., Washizuka M., Kobayashi N., Nakata N., Ikeda Y. Differential effects of intracerebroventricular AF64A injection, nucleus basal is of Meynert lesion, and scopolamine on place navigation and open-field behavior of rats. Yakubutsu Seishin Kodo 1992; 12: 85–92
   PubMedGoogle Scholar
• Page S. Aggression in Alzheimer's disease. Nursing Standard 1992; 6: 37–39
   PubMedGoogle Scholar
• Palmer A. M., Gershon S. Is the neuronal basis of Alzheimer's disease cholinergic or gluatamatergic?. FASEB Journal 1990; 4: 2745–2752
   PubMedGoogle Scholar
• Paxinos G., Watson C. The rat brain in stereotaxic coordinates. Academic Press, Sydney 1982
   Google Scholar
• Pearce J. Extrapyramidal disorders of the Alzheimer's disease. European Neurology 1974; 12: 94–103
   PubMed Web of Science ®Google Scholar
• Pearson R. C. A., Sofroniew M. W., Cucllo A. C., Powell T. P. S., Eckenstein F., Esiri M. M., Wilcock G. K. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Research 1983; 289: 375–379
   PubMed Web of Science ®Google Scholar
• Procter A. W., Francis P. T., Stratmann G. C., Bowen D. M. Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms. Neurochemical Research 1992; 17: 917–922
   PubMed Web of Science ®Google Scholar
• Reifler B. V., Larson E., Hanlet R. Co-existence of cognitive impairment and depression in geriatric outpatients. American Journal of Psychiatry 1982; 139: 1074–1079
   Web of Science ®Google Scholar
• Shannon H. E., Peters S. C. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice. Journal of Pharmacology and Experimental Therapeutics 1990; 255: 549–553
   PubMed Web of Science ®Google Scholar
• Shields C. G. Family interaction and caregivers of Alzheimer's disease patients: correlates of depression. Family Process 1992; 31: 19–33
   PubMed Web of Science ®Google Scholar
• Simonić A., Župan G. Passive avoidance behavior changes produced by the atropinisation and the nucleus basalis lesion in rats. higoslavica Physiologica et Pharmacologic a Acta 1989; 25: 135–136, (suppl. 7)
   Google Scholar
• Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Research Reviews 1988; 13: 103–118
   Google Scholar
• Sparks D. L., DeKosky S. T., Markesbery W. R. Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus. Archives of Neurology 1988; 45: 994–999
   PubMedGoogle Scholar
• Stewart W. J., Blain S. Dose-response effects of scopolamine on activity in an open field. Psychopharmacology 1975; 44: 291–295
   PubMed Web of Science ®Google Scholar
• Szabo S. Stress and gastroduodenal ulcers. Stress 1980; 1: 25–36
   Google Scholar
• Szabo S. Understanding biologic stress for study design and interpretation of results. Digestive Disease and Sciences 1985; 30: 28S–31S
   Web of Science ®Google Scholar
• Teri L., Wagner A. Alzheimer's disease and depression. Journal of Consulting and Clinical Psychology 1992; 60: 379–391
   PubMed Web of Science ®Google Scholar
• Touitou Y., Reinberg A., Bogdan A., Auzeby A., Beck H., Touitou C. Age-related changes in both circadian and seasonal rhythms of rectal temperature with special reference to senile dementia of Alzheimer type. Gerontology 1986; 32: 110–118
   PubMed Web of Science ®Google Scholar
• Valzelli L. Serotoninergic inhibitory control of experimental aggression. Pharmacological Research Communication 1982; 14: 1–13
   PubMedGoogle Scholar
• Wallace W. C., Bragin V., Robakis N. K., Sambamurti K., VanderPutten D., Merril C. R., Davis K. L., Santucci A. C., Haroutunian V. Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert. Molecular Brain Research 1991; 10: 173–178
   PubMedGoogle Scholar
• Walsh R. N., Cummins R. A. The open-field test: a critical review. Psychological Bulletin 1976; 83: 482–504
   PubMed Web of Science ®Google Scholar
• Wenk H. The nucleus basalis magnocellularis Meynert (NBmM) complex–a central integrator of coded “limbic signals” linked to neocortical modular operation? A proposed (heuristic) model of function. Journal fur Hirnforschung 1989; 30: 127–151
   PubMedGoogle Scholar
• Whishaw I., O'Connor W., Dunnett S. Disruption of central cholinergic systems in the rat brain by basal forebrain lesions or atropine: effects on feeding, sensorimotor behavior, locomotor activity and spatial navigation. Behavioral Brain Research 1985; 17: 103–115
   PubMed Web of Science ®Google Scholar
• Whitehouse P. J., Price D. L., Clark A. W., Coyle J. T., De Long M. R. Alzheimer disease: evidence of selective loss of cholinergic neurons in the nucleus basalis. Annals of Neurology 1981; 10: 122–126
   PubMed Web of Science ®Google Scholar
• Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., De Long M. R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215: 1237–1239
   PubMed Web of Science ®Google Scholar